HUTCHMED (China) Limited
HMDCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $630,201 | $837,999 | $426,409 | $356,128 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Cost of Goods Sold | $348,884 | $384,447 | $311,103 | $258,234 |
| Gross Profit | $281,317 | $453,552 | $115,306 | $97,894 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| R&D Expenses | $212,109 | $302,001 | $391,449 | $314,601 |
| G&A Expenses | $64,296 | $79,784 | $92,173 | $89,298 |
| SG&A Expenses | $112,913 | $133,176 | $136,106 | $127,125 |
| Sales & Mktg Exp. | $48,617 | $53,392 | $43,933 | $37,827 |
| Other Operating Expenses | -$3,095 | -$3,134 | -$4,556 | -$15,515 |
| Operating Expenses | $321,927 | $432,043 | $522,999 | $426,211 |
| Operating Income | -$40,610 | $18,375 | -$413,231 | -$342,701 |
| % Margin | -6.4% | 2.2% | -96.9% | -96.2% |
| Other Income/Exp. Net | $85,972 | $87,228 | $51,703 | $188,088 |
| Pre-Tax Income | $45,362 | $105,603 | -$361,528 | -$154,613 |
| Tax Expense | $7,192 | $4,509 | -$283 | $11,918 |
| Net Income | $37,729 | $100,780 | -$360,835 | -$194,648 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS | 0.044 | 0.12 | -0.43 | -0.24 |
| % Growth | -63.3% | 127.9% | -79.2% | – |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.24 |
| Weighted Avg Shares Out | 855,352 | 849,654 | 847,144 | 792,685 |
| Weighted Avg Shares Out Dil | 872,829 | 869,196 | 847,144 | 792,685 |
| Supplemental Information | – | – | – | – |
| Interest Income | $40,080 | $36,145 | $9,599 | $2,076 |
| Interest Expense | $2,872 | $759 | $652 | $592 |
| Depreciation & Amortization | $12,341 | $8,226 | $8,685 | $7,166 |
| EBITDA | $14,164 | $67,431 | -$402,061 | -$207,274 |
| % Margin | 2.2% | 8% | -94.3% | -58.2% |